REPLAY! This Week On HedgeyeTV

Our deep bench of analysts take to HedgeyeTV every weekday to update subscribers on Hedgeye's high conviction stock ideas and evolving macro trends. Whether it's on The Macro ShowReal-Time Alerts Live or other exclusive live events, HedgeyeTV is always chock full of insight.


Below is a taste of the most recent week in HedgeyeTV. (Like what you see? Click here to subscribe for free to our YouTube channel.)




1. Airbnb Is an Existential Threat to the Hotel Industry (6/11/2016)



In this brief excerpt from The Macro Show, our Gaming, Lodging & Leisure Sector Head Todd Jordan explains why Airbnb is a significant threat to the hotel industry.


2. This Is One of the Top-3 Stock Market Bubbles in History (6/10/2016)



In this excerpt from The Macro Show this morning, Hedgeye CEO Keith McCullough and Demographics Sector Head Neil Howe discuss why “the stock market is one gigantic emotional rollercoaster” perched perilously at its peak. 


3. The Bullish Case for Life Insurance | Q&A with Neil Howe (6/9/2016)



Hedgeye Managing Director Neil Howe held a live Q&A on Thursday June 9 in which he discussed why life insurance company shares have been beaten down since the Great Recession, and makes the case for their comeback.


Click here to read Howe’s associated About Everything piece.


Click here to access the associated slides.


4. Benn Steil: Donald Trump Is a Clear and Present Market Danger (6/8/2016)



Would a Trump presidency be bad news for the global economy and markets? Benn Steil, director of international economics at the Council on Foreign Relations and author of "The Battle of Bretton Woods" thinks so. He discusses the disconcerting and adverse consequences a Trump presidency may have with Hedgeye CEO Keith McCullough.


5. Drake: Contextualizing the Biggest Deceleration in Credit Growth Since 2010 (6/7/2016)



In this brief discussion, Hedgeye U.S. Macro analyst Christian Drake analyzes the trend in consumer credit growth, which has been supporting consumption in the face of slowing income growth.


6. Yikes: Yellen’s Favorite Market Indicator Hits 7-Year Low (6/6/2016)



Hedgeye U.S. macro analyst Christian Drake takes a look at the “Labor Market Conditions Index” which just posted its 5th consecutive month of negative reading (worse since 2009) and what it portends for Fed policy.


7. McCullough: The Most Asymmetric US Corporate Profit Risk (Ever) (6/6/2016)



In this brief excerpt from The Macro Show this morning, Hedgeye CEO Keith McCullough reviews the “Fantasy Island” earnings risk blinding many investors and why second and third quarter earnings for most sectors will be “awful.”


Takeaway: Within 18 months the Pentagon will reduce its planned F-35 acquisition objective by a third and its long term annual buy rate by 15%.

Like a mighty elk pursued by wolves, the world’s largest defense program, the Joint Strike Fighter, is being stalked by a series of programs that individually are not threatening but as a pack can mortally wound the program.  

On Friday, 17 June at 11:00 EDT, Hedgeye’s LtGen “Emo” Gardner will provide investors the context for the first ever appearance of the F-35 at the world’s most important aerospace show, the Farnborough International Airshow, July 11-17. He will cover current US TacAir plans in general,  the $1T JSF program specifically and where the surging US TacAir market is likely to be five years from now.  

Call in details will be provided.



Airbnb Is an Existential Threat to the Hotel Industry


In this brief excerpt from The Macro Show, our Gaming, Lodging & Leisure Sector Head Todd Jordan explains why Airbnb is a significant threat to the hotel industry and its potential for a big IPO.

Daily Trading Ranges

20 Proprietary Risk Ranges

Daily Trading Ranges is designed to help you understand where you’re buying and selling within the risk range and help you make better sales at the top end of the range and purchases at the low end.

The Week Ahead

The Economic Data calendar for the week of the 13th of June through the 17th of June is full of critical releases and events. Here is a snapshot of some of the headline numbers that we will be focused on.



The Week Ahead - 06.10.16 Week Ahead

This Week In Hedgeye Cartoons

Our cartoonist Bob Rich captures the tenor on Wall Street every weekday in Hedgeye's widely-acclaimed Cartoon of the Day. Below are his five latest cartoons. We hope you enjoy his humor and wit as filtered through Hedgeye's market insights. (Click here to receive our daily cartoon for free.)




1. LOST (6/10/2016)

This Week In Hedgeye Cartoons - Fed cartoon 06.10.2016


What can we expect from the FOMC next week?


"Remember that projecting an air of confidence and maintaining maximum policy optionality requires carefully treading the hawkishly dovish messaging line … or maybe it’s the dovishly hawkish line," Hedgeye U.S. Macro analyst Christian Drake wrote in today's Early Look.


In other words, if you're hoping for clarity, don't hold your breath. There's more nonsensical Fed-speak to come.


2. Drinking The Kool-Aid? (6/9/2016)

This Week In Hedgeye Cartoons - central bank kool aid 06.09.2016


Did you drink the central planning Kool-Aid?


3. Squirrelly (6/8/2016)

This Week In Hedgeye Cartoons - S P 500 cartoon 06.08.2016


This one speaks for itself.


4. Sobriety Checkpoint Ahead (6/7/2016)

This Week In Hedgeye Cartoons - Yellen cart 06.07.2016


FYI: The Yellen Fed isn't "data dependent." It's S&P 500 dependent.


5. Yellen & Screamin' (6/6/2016)

This Week In Hedgeye Cartoons - Hawk dove cartoon 06.06.2016


The mercurial Fed has pivoted from Hawkish (in December) to Dovish (March/April) to Hawkish (May). With today's speech, market consensus now perceives Yellen & Co. as flipping back to Dovish here in June. Clearly, the Fed is perpetuating a massive amount of volatility in macro markets.

Investing Ideas Newsletter

Takeaway: Current Investing Ideas: DNKN, HOLX, DE, HBI, LAZ, MDRX, FL, NUS, JNK, TIF, WAB, ZBH, GLD, MCD, TLT

Investing Ideas Newsletter - central bank kool aid 06.09.2016


Below are our analysts’ new updates on our fifteen current high conviction long and short ideas. As a reminder, if nothing material has changed in the past week which would affect a particular idea, our analyst has noted this.


Please note that we added Dunkin' Brands (DNKN) to the short side of Investing Ideas this week. Restaurants analyst Howard Penney will send out a full stock report on DNKN next week. We will send CEO Keith McCullough’s updated levels for each ticker in a separate email.


To view our analyst's original report on Junk Bonds click here and here for Gold.


It was an excellent week for our Macro team's #GrowthSlowing call. Long Bonds (TLT) led the charge up +6.4% with Gold (GLD) up +2.4% versus a flat week for the S&P 500.


No matter what side of the reflation/deflation trade you’re on, the growth in global demand continues to decelerate on a trending basis. The debate is no longer whether or not growth is slowing. The real debate centers on the policy response and the market reaction to that policy response. While that question presents us with “open the envelope” risk, #GrowthSlowing will continue to be the bull catalyst for U.S. Treasuries whatever the policy response as the slow march to zero yields globally goes on. Remember:


Central planners can’t print growth.


Only 35% of country and regional PMI figures across manufacturing, services and composite readings are both expanding (i.e. > 50) and accelerating sequentially as of last month. The rest are either expanding but decelerating or in outright contraction (i.e. < 50). The JPMorgan Global Composite PMI Index in the chart below is a good birds-eye-view on the deceleration in broad-base PMI measures:


Investing Ideas Newsletter - pmi


Hitting the demand slowdown on the consumption side of the domestic economy, we highly suggest watching the clip below from earlier this week. Macro analyst Christian Drake breaks down credit’s role in the consumption cycle when consumer spending starts to slow. Credit has the ability to pull forward spending, but when it too begins to roll, 69% of the economy starts tumble downward:


Click the image below to watch.

Investing Ideas Newsletter - credit


With the aforementioned evidence of continued economic contraction, we’re confident sticking with growth-slowing allocations (TLT) while waiting and watching on deflation/reflation exposure. As Keith McCullough outlined in Thursday’s Early Look:


“It was an easier call to make that growth would slow than it was that being right on #GrowthSlowing would get people to chase Reflation Charts that have been blowing investors up for 3 years. I don’t think of this as a mistake yet (this “bull” only started in MAR/APR). I’m actually thinking of it as an opportunity. While I haven’t been short Energy this year (we were last year with our #StrongDollar Deflation call), I haven’t been long it either.”


To sum things up, stay away from the guessing game and stick to what is empirically evident. A stronger USD over the longer term is a probable scenario in our book. We expect the Fed, and all central banks for that matter, will try to combat deflation. That said, global currencies all burning at the same time makes a compelling case for GLD, as gold knows no currency. You can sell it in local currency all over the world. Scary but true.


To view our analyst's original report on McDonald's click here


There have been rumblings in the news that McDonald's (MCD) 2Q comps have slowed due to the temporary replacement of the 2 for $5 value platform for Monopoly. This has clearly been reflected in the stock as of late, as MCD has underperformed the S&P 500 over the last month.


Despite this near term headwind, we still strongly believe in the long-term story for MCD and remain confident that once they get their value platform right nationally, they will be just fine. In the short to intermediate term, as we wait for a solidified value platform, this recent underperformance represents a great buying opportunity. We remain LONG MCD. 


To view our analyst's original report on Wabtec click here.


No update on Wabtech (WAB) this week but Hedgeye Industrials analyst Jay Van Sciver reiterates his short call.


To view our analyst's original report on Zimmer Biomet click here. Below is an update on ZBH from Healthcare analyst Tom Tobin.


We got the latest update to our #ACATaper thesis this week with the JOLTS report. Despite a slight sequential uptick in the absolute number of Healthcare Job Openings (1,015 April / 957 March), on a trending basis, growth was the slowest in 7 quarters with the 3-month YoY growth rate at +12.2%. JOLTS as a % of Healthcare Employment remains extended at +2.1 standard deviations, suggesting there is a lot more downside to go as the #ACATaper takes hold and the U.S. Medical Economy mean reverts. 


Of the thousands of macro and fundamental data series we track on a daily basis, Healthcare Job Openings (JOLTS), prove to have the most consistent and reliable relationship to utilization trends in the industry. 


Investing Ideas Newsletter - 20160610 JOLTS Slowing


We think the ACA increased volume temporarily in 2014 and 2015 for a host of Healthcare companies including hospitals, physician offices and orthopedic manufacturers. As we enter the late part of the economic cycle broadly and the inflated Healthcare caused by the ACA, we think Zimmer Biomet (ZBH) and its peers will be struggling with declining volume and increasing price pressure.


The chart below shows pent-up demand for Knee Replacement Surgery among newly insured from a Society of Actuaries Analysis of claims data in Kansas.


Investing Ideas Newsletter - 20160610 PentUpDemandNewlyInsured


Quick Thoughts on LDR Acquisition


Earlier this week, Zimmer-Biomet announced the purchase of LDR (LDRH) for a total consideration of ~$1.0 billion, or 5.5x 2016 Sales. The transaction will be indirectly funded through issuance of $750 million of unsecured bonds expected to be priced and issued in 2H16. The LDR deal increases ZBH's market share in spine from 5% to 7%, but it will remain well behind competitors Medtronic at 31% and DePuy at 16%.


Spine is more favorably disposed from a demographic and payer mix perspective, but is also likely the next target for bundled payments. While ZBH needed to improve their Spine portfolio, we were surprised by the timing of the announcement so soon after closing Biomet and taking on ~$10 billion in debt to fund the deal. We also have a hard time understanding how the LDR is going to be neutral/accretive to earnings in 2017/2018 given the high price tag and management having no intention of reducing forecasted levels of investment.


To view our analyst's original report on Hanesbrands click here


One piece of the Hanesbrands (HBI) business model that is commonly misunderstood is how utilization impacts their margins, since they own about 2/3 of their own production. The chart below outlines the difference between owned manufacturing and outsourced manufacturing. The graph on the right shows your typical apparel/footwear company set-up, where goods are made by a third party. For every unit of demand, the increase in cash flow or profits is the same.


However, with owned manufacturing each incremental unit of demand comes with accelerated profits and cash flow because it can scale up units and leverage the fixed manufacturing costs. Right now HBI is operating at over 90% utilization, and therefore has peak profitability per demand unit. 


The problem now is that the leverage works both ways, so as demand drops, profits and cash flow decline at an accelerating rate. We believe demand is slowing and will continue to slow driven both by competition and macro factors. As this happens utilization will drop and margin and cash flow will decline rapidly. On that note, organic growth has been negative for 3 of the last 4 quarters.


Investing Ideas Newsletter - 6 10 2016 HBI II


To view our analyst's original report on Nu Skin click here


No update on Nu Skin (NUS) this week but Hedgeye Consumer Staples analysts Howard Penney and Shayne Laidlaw reiterate their short call.


To view our analyst's original report on Allscripts click here. Below is an excerpt from an institional research note on Allscripts (MDRX) written by our Healthcare team.



Takeaway: Allscripts did not invest resources into the Homecare product, which was old to begin with and resulted in competitive losses.


Investing Ideas Newsletter - mdrx


We spoke with a former Allscripts Homecare Salesperson, who also spent many years working for Eclipsys as a Sunrise Rep prior to the merger. The purpose was to get a better understanding of Allscripts position in the Home Health market and rationale behind the Netsmart deal. Given chronic underinvestment and weak market prospects, we can see how the divestiture makes sense from a P&L perspective for core Allscripts. However, anecdotes suggest that current clients were not pleased with the news and we have a hard time grasping (absent additional investment) how the Homecare business is going to do much better under Netsmart's control.


"Last shoe has dropped and Netsmart has run away with the dish and the spoon... any sense of stability is now gone." - Large Allscripts Home Health Client

key takeaways

  • Allscripts did not invest resources into the Homecare product, which was old to begin with and resulted in competitive losses.
  • Homecare Homebase entered the market 5-years ago and began to take share from legacy vendors, especially Allscripts whose market share shrank from 13% in 2011 to 7% in 2015.
  • Allscripts is currently doing whatever it takes to win new Sunrise business... Cutting maintenance from 18-20% of system sale to 8-10%, maintenance holidays, excluding or limiting CPI adjustment.
  • Operational focus under Paul Black's leadership has come at the cost of product development and the sales organization.


To view our analyst's original report on Tiffany click here


We're nearly to the end of retail earnings season and it appears that Tiffany (TIF) will post the 2nd worst comparable store sales gain in all of retail at -9%. The only worse comp we have seen is Lumber Liquidators, which is still feeling the hangover from national news stories noting its product is full of carcinogenic Formaldehyde.


We find it hard to believe that Tiffany is trading at 17x earnings considering the following factors:


  • It put up one of the worst growth rates in the industry.
  • It is tracking to 2 consecutive years of high single-digit earnings declines with no clear plan to reverse the business trend.
  • We are still in the early stages of a consumer and economic slowdown, as global GDP estimates are being constantly revised downwards.


Ultimately, we believe the multiple will come down when the market realizes that the consensus expectation for a reacceleration in earnings growth to double digits in 2017 is not very likely to happen.


We remain short TIF stock.


To view our analyst's original report on Lazard click here


No update on Lazard (LAZ) this week but Hedgeye Financials analyst Jonathan Casteleyn reiterates their short call.


To view our analyst's original report on Foot Locker click here.


The biggest near term threat to Foot Locker (FL) earnings and the stock is slowing comparable store sales. In 1Q16 comps slowed to 2.9% from 7.9% the prior quarter. At the same time, main banner e-commerce held relatively steady at about 20% after slowing from 40%+ in 1H15. Our traffic tracking showed a similar trend over the last year. The 2Q to date is showing a clear slowing from 1Q. 


The company noted on their conference call three weeks ago that total comps were running negative in the quarter-to-date, saying it was from a shifted Nike shoe launch. But since then we have not seen an improvement in online traffic, which has actually weakened slightly. This could mean more negative pressure on the Footlocker comps over the near term.


Investing Ideas Newsletter - 6 10 2016 FL II


To view our analyst's original report on Deere & Company click here.


Is the agricultural economy at trough?


If credit and debt trends are any indication, the answer is no. Farm debt is expanding, which is not a characteristic of an industry at trough. The reversal in farm credit metrics portends lower farmland values, higher credit losses, and lower farm spending.  


For Deere & Company (DE), credit trends are a critical valuation point since many investors place a high ‘trough’ multiple on the ~40% of net income from the captive finance subsidiary. We think investors are inappropriately extrapolating the benefits of a robust farm economy and gains in farmland values when evaluating DE’s finance subsidiary. Despite a recent flurry of optimism, we continue to see 30%-50% relative downside for shares of DE, with tightening credit as a key catalyst.


Investing Ideas Newsletter - de 6 10


Click here to view our analyst's stock report on Hologic (HOLX).

Early Look

daily macro intelligence

Relied upon by big institutional and individual investors across the world, this granular morning newsletter distills the latest and most vital market developments and insures that you are always in the know.